Payment overview · 2025
General Payments
2 reported records · 2 companies
Healthcare provider profile · identity verified
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · SNEEDVILLE, TN · NPI 1477956076
Verified facts
CMS Open Payments records show Lori B Ogle, FNP received $41.86 in general payments during 2025 across 2 reported records.
Vanda Pharmaceuticals Inc. accounted for 52.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
2 reported records · 2 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $21.92 | 52.4% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $19.94 | 47.6% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $41.86 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $21.92 | 1 | 2025 |
Source payment records
|
|||||
| HETLIOZ Normalized: hetlioz |
Drug | Vanda Pharmaceuticals Inc. | $21.92 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $19.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 620 | 43 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 547 | 56 |
| Eliquis | Apixaban | 297 | 33 |
| Pantoprazole Sodium | Pantoprazole Sodium | 243 | 53 |
| Levothyroxine Sodium | Levothyroxine Sodium | 237 | 33 |
| Divalproex Sodium | Divalproex Sodium | 198 | 36 |
| Sertraline Hcl | Sertraline Hcl | 189 | 30 |
| Furosemide | Furosemide | 186 | 40 |
| Atorvastatin Calcium | Atorvastatin Calcium | 177 | 41 |
| Buspirone Hcl | Buspirone Hcl | 162 | 31 |
| Potassium Chloride | Potassium Chloride | 154 | 34 |
| Lorazepam | Lorazepam | 152 | 21 |
| Gemtesa | Vibegron | 138 | 11 |
| Klor-Con 10 | Potassium Chloride | 125 | 24 |
| Amlodipine Besylate | Amlodipine Besylate | 123 | 23 |
| Mirtazapine | Mirtazapine | 121 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 119 | 24 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 107 | 19 |
| Alprazolam | Alprazolam | 105 | suppressed |
| Famotidine | Famotidine | 104 | 27 |
| Lisinopril | Lisinopril | 102 | 21 |
| Pregabalin | Pregabalin | 92 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 89 | 12 |
| Trazodone Hcl | Trazodone Hcl | 89 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 87 | 13 |
| Olanzapine | Olanzapine | 81 | 12 |
| Metoprolol Succinate | Metoprolol Succinate | 77 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 76 | 15 |
| Metoprolol Tartrate | Metoprolol Tartrate | 75 | 26 |
| Bumetanide | Bumetanide | 68 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 66 | 20 |
| Fentanyl | Fentanyl | 66 | suppressed |
| Omeprazole | Omeprazole | 66 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 64 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 63 | 12 |
| Tramadol Hcl | Tramadol Hcl | 63 | 17 |
| Albuterol Sulfate | Albuterol Sulfate | 59 | 38 |
| Midodrine Hcl | Midodrine Hcl | 59 | 11 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | 14 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 53 | suppressed |
| Metformin Hcl | Metformin Hcl | 53 | suppressed |
| Jardiance | Empagliflozin | 52 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 49 | 24 |
| Ropinirole Hcl | Ropinirole Hcl | 49 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 48 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 48 | suppressed |
| Allopurinol | Allopurinol | 44 | 12 |
| Clonazepam | Clonazepam | 43 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 40 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 40 | 12 |
| Prednisone | Prednisone | 39 | 27 |
| Memantine Hcl | Memantine Hcl | 36 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 36 | suppressed |
| Tradjenta | Linagliptin | 36 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 35 | suppressed |
| Viberzi | Eluxadoline | 35 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 34 | suppressed |
| Carvedilol | Carvedilol | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 29 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 29 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 24 |
| Nystatin | Nystatin | 28 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 17 |
| Brilinta | Ticagrelor | 27 | suppressed |
| Levofloxacin | Levofloxacin | 26 | 19 |
| Bethanechol Chloride | Bethanechol Chloride | 25 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 25 | 11 |
| Lidocaine Hcl | Lidocaine Hcl | 25 | 13 |
| Fluconazole | Fluconazole | 24 | 17 |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Losartan Potassium | Losartan Potassium | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 14 |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Risperidone | Risperidone | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 15 |
| Azithromycin | Azithromycin | 21 | 14 |
| Linzess | Linaclotide | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 15 |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 20 | 20 |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Cefdinir | Cefdinir | 17 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 17 | 11 |
| Ertapenem | Ertapenem Sodium | 17 | suppressed |
| Finasteride | Finasteride | 17 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 17 | 11 |
| Spironolactone | Spironolactone | 17 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Baclofen | Baclofen | 14 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 14 | 12 |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $41.86 · 2 records | Vanda Pharmaceuticals Inc. | FANAPT, HETLIOZ, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error